Market Place
Piramal's expertise across varied technologies makes them a partner of choice for innovators & generic companies worldwide. 
X
Please Wait
Applying Filters...
01 Piramal Pharma Limited (1)
02 Curia Italy S.r.l. (1)
03 DARMERICA, LLC (2)
01 MECAMYLAMINE HYDROCHLORIDE (1)
02 MGF (Mechano Growth Factor) Acetate (1)
03 Mecamylamine Hydrochloride (1)
04 PEG-MGF Acetate (1)
01 U.S.A (4)
83
PharmaCompass offers a list of Mecamylamine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mecamylamine Hydrochloride manufacturer or Mecamylamine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mecamylamine Hydrochloride manufacturer or Mecamylamine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Mecamylamine Hydrochloride API Price utilized in the formulation of products. Mecamylamine Hydrochloride API Price is not always fixed or binding as the Mecamylamine Hydrochloride Price is obtained through a variety of data sources. The Mecamylamine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A INCRELEX manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of INCRELEX, including repackagers and relabelers. The FDA regulates INCRELEX manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. INCRELEX API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A INCRELEX supplier is an individual or a company that provides INCRELEX active pharmaceutical ingredient (API) or INCRELEX finished formulations upon request. The INCRELEX suppliers may include INCRELEX API manufacturers, exporters, distributors and traders.
click here to find a list of INCRELEX suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing INCRELEX as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for INCRELEX API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture INCRELEX as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain INCRELEX and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a INCRELEX NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of INCRELEX suppliers with NDC on PharmaCompass.
We have 3 companies offering INCRELEX
Get in contact with the supplier of your choice:
